New Key Statistics Module, Z-Score and F-Score
NAS:CNTA Key Ratios
| Market Cap $ M | 2,228.19 |
| Enterprise Value $ M | 1,794.46 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.37 |
| Price/Sales | 236.64 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 6.00 |
| EPS (TTM) $ | -1.52 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -12.67 |
| EV-to-EBITDA | -12.76 |
| PEG | -- |
| Shares Outstanding M | 131.85 |
| Net Margin (%) | -2,353.20 |
| Operating Margin % | -2,358.87 |
| Pre-tax Margin (%) | -2,310.33 |
| Quick Ratio | 21.52 |
| Current Ratio | 21.52 |
| ROA % (ttm) | -38.87 |
| ROE % (ttm) | -53.87 |
| ROIC % (ttm) | -240.17 |
| Dividend Yield % | -- |
| Altman Z-Score | 10.80 |
CNTA Number of Guru Trades
CNTA Volume of Guru Trades
Gurus Latest Trades with NAS:CNTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CNTA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Centessa Pharmaceuticals PLC Insider Transactions
No Available Data
News about NAS:CNTA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers